Shree Pacetronix Ltd
NSE: BSE: 527005
₹116.65
(7.41%)
Sun, 29 Mar 2026, 07:58 pm
Market Cap428.64M
PE Ratio16.89
Dividend0
Health Technology
Medical Specialties
24.5KShree Pacetronix Analysis
dividend
- Unable to evaluate Shree Pacetronix's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Shree Pacetronix's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Shree Pacetronix is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Shree Pacetronix is profitable, therefore cash runway is not a concern.
- Shree Pacetronix is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (42.9%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 1.9x debt.
- Shree Pacetronix's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has increased over the past 5 years (47.6% vs 62.6% today).
- Interest payments on debt are not well covered by earnings (EBIT is 1.4x annual interest expense, ideally 3x coverage).
- Shree Pacetronix's level of debt (62.6%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- Atul's remuneration is lower than average for companies of similar size in India.
- Atul's compensation has been consistent with company performance over the past year, both up more than 20%.
- The average tenure for the Shree Pacetronix board of directors is less than 3 years, this suggests a new board.
- The average tenure for the Shree Pacetronix management team is less than 2 years, this suggests a new team.
misc
- Shree Pacetronix is not covered by any analysts.
- BSE:527005 has not traded for 64 days.
past
- Shree Pacetronix has delivered over 20% year on year earnings growth in the past 5 years.
- Shree Pacetronix used its assets more efficiently than the IN Medical Equipment industry average last year based on Return on Assets.
- Shree Pacetronix has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Shree Pacetronix's 1-year earnings growth is less than its 5-year average (20.5% vs 43.7%)
- Shree Pacetronix has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Shree Pacetronix's earnings growth has not exceeded the IN Medical Equipment industry average in the past year (20.5% vs 21.7%).
value
- Shree Pacetronix's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Shree Pacetronix's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Shree Pacetronix is overvalued based on assets compared to the IN Medical Equipment industry average.
- Shree Pacetronix is overvalued based on earnings compared to the IN Medical Equipment industry average.
- Shree Pacetronix is overvalued based on earnings compared to the India market.
- BSE:527005 is flat (0%) underperforming the Medical Equipment industry which returned 9.6% over the past month.
- BSE:527005 is flat (0%) underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800